← All proposals

[Funding] Fission Pharma

CDP-2 · 2024-04-25 → 2024-04-30 · Closed

Original co-funding proposal (with VitaDAO) for Fission Pharma's P110-mimetic drug discovery program targeting chronic inflammation/mitochondrial dysfunction. $83,333 co-funding by Cerebrum for a 20% IP-NFT share, part of a $250,000-$333,333 total financing structure (later revised by CDP-14).

Vote result

ChoiceVotes (NEURON)Share
For9,761,000,000100.0%
Against00.0%
Abstain00.0%

Quorum: 3,870,000,000 NEURON

Sources

Last reviewed: 2026-07-22